Insiders · BPMC

BPMC insider transactions

Blueprint Medicines Corporation (BPMC) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

BPMC insiders

Everyone who has filed a Form 3, 4, 5 or 144 at Blueprint Medicines Corporation, latest first. Follow anyone to get their next filing.

• Michael LandsittelChief Financial Officer-$4.89M
• Habib J DableDirector, since June 2022
• John TsaiDirector, since January 2023
• Ariel HurleyPrincipal Accounting Officer-$4.19M
• Lonnel CoatsDirector-$1.87M
• L. Becker HewesChief Medical Officer, since January 2021-$7.7M
• Lynn SeelyDirector
• Percy H. CarterChief Scientific Officer, since May 2021-$1.94M
• Kate HavilandChief Executive Officer, Director+$48.4K-$4.2M
• Christina RossiChief Operating Officer-$3.32M
• Alexis BorisyDirector
• Mark Alan GoldbergDirector+$300K
• Fouad NamouniPresident, R & D-$2.18M
• Daniella BeckmanDirector, since December 2021
• Tracey L McCainEVP & Chief Legal Officer-$5.17M
• Debra Durso-BumpusChief People Officer-$11.6M
• Philina LeeChief Commercial Officer, since April 2022-$5.31M
• Jeffrey W. AlbersDirector-$35.4M
• Nicholas LydonDirector
• Christopher K. MurrayChief Technical Operations-$1.84M
• George DemetriDirector+$827-$586
• Marion DorschOfficer-$758K

Recent Form 3, 4, and 5 filings for BPMC

• 477d
  Chief Financial Officer Landsittel Michael returned 51,102 shares to the company and was granted 21,353 shares, closing all direct ownership in the company (SEC Form 4)

  4 - Blueprint Medicines Corp (0001597264) (Issuer)
• 477d
  Director Dable Habib J returned 3,902 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Blueprint Medicines Corp (0001597264) (Issuer)
• 477d
  Principal Accounting Officer Hurley Ariel was granted 2,460 shares and returned 16,146 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Blueprint Medicines Corp (0001597264) (Issuer)
• 477d
  Director Tsai John returned 3,902 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Blueprint Medicines Corp (0001597264) (Issuer)
• 477d
  Director Coats Lonnel returned 6,144 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Blueprint Medicines Corp (0001597264) (Issuer)
• 477d
  Chief Medical Officer Hewes L. Becker was granted 21,353 shares and returned 50,165 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Blueprint Medicines Corp (0001597264) (Issuer)
• 477d
  Director Seely Lynn returned 3,902 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Blueprint Medicines Corp (0001597264) (Issuer)
• 477d
  Chief Scientific Officer Carter Percy H. returned 56,614 shares to the company and was granted 21,353 shares, closing all direct ownership in the company (SEC Form 4)

  4 - Blueprint Medicines Corp (0001597264) (Issuer)
• 477d
  Chief Executive Officer Haviland Kate was granted 129,210 shares and returned 224,410 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Blueprint Medicines Corp (0001597264) (Issuer)
• 477d
  Chief Operating Officer Rossi Christina was granted 39,456 shares and returned 82,374 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Blueprint Medicines Corp (0001597264) (Issuer)
• 477d
  Director Borisy Alexis returned 3,902 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Blueprint Medicines Corp (0001597264) (Issuer)
• 477d
  Director Goldberg Mark Alan returned 3,902 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Blueprint Medicines Corp (0001597264) (Issuer)
• 477d
  PRESIDENT, R & D Namouni Fouad was granted 39,456 shares and returned 83,281 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Blueprint Medicines Corp (0001597264) (Issuer)
• 477d
  Director Beckman Daniella returned 3,902 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Blueprint Medicines Corp (0001597264) (Issuer)
• 477d
  EVP & Chief Legal Officer Mccain Tracey L was granted 21,353 shares and returned 51,103 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Blueprint Medicines Corp (0001597264) (Issuer)
• 477d
  Chief People Officer Durso-Bumpus Debra was granted 21,353 shares and returned 51,103 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Blueprint Medicines Corp (0001597264) (Issuer)
• 477d
  Chief Commercial Officer Lee Philina was granted 21,353 shares and returned 50,165 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Blueprint Medicines Corp (0001597264) (Issuer)
• 477d
  Director Albers Jeffrey W. returned 5,777 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Blueprint Medicines Corp (0001597264) (Issuer)
• 490d
  CHIEF OPERATING OFFICER Rossi Christina sold $150,309 worth of shares (1,172 units at $128.25), decreasing direct ownership by 2% to 63,546 units (SEC Form 4)

  4 - Blueprint Medicines Corp (0001597264) (Issuer)
• 490d
  CHIEF SCIENTIFIC OFFICER Carter Percy H. sold $134,791 worth of shares (1,051 units at $128.25), decreasing direct ownership by 2% to 53,155 units (SEC Form 4)

  4 - Blueprint Medicines Corp (0001597264) (Issuer)
• 504d
  Director Albers Jeffrey W. was granted 3,902 shares, increasing direct ownership by 3% to 150,532 units (SEC Form 4)

  4 - Blueprint Medicines Corp (0001597264) (Issuer)
• 504d
  Director Goldberg Mark Alan was granted 3,902 shares, increasing direct ownership by 21% to 22,156 units (SEC Form 4)

  4 - Blueprint Medicines Corp (0001597264) (Issuer)
• 504d
  Director Seely Lynn was granted 3,902 shares, increasing direct ownership by 29% to 17,156 units (SEC Form 4)

  4 - Blueprint Medicines Corp (0001597264) (Issuer)
• 504d
  Director Beckman Daniella was granted 3,902 shares, increasing direct ownership by 36% to 14,744 units (SEC Form 4)

  4 - Blueprint Medicines Corp (0001597264) (Issuer)
• 504d
  Director Borisy Alexis was granted 3,902 shares, increasing direct ownership by 5% to 78,062 units (SEC Form 4)

  4 - Blueprint Medicines Corp (0001597264) (Issuer)
• 504d
  Director Dable Habib J was granted 3,902 shares, increasing direct ownership by 45% to 12,644 units (SEC Form 4)

  4 - Blueprint Medicines Corp (0001597264) (Issuer)
• 504d
  Director Coats Lonnel was granted 3,902 shares, increasing direct ownership by 174% to 6,144 units (SEC Form 4)

  4 - Blueprint Medicines Corp (0001597264) (Issuer)
• 504d
  Director Tsai John was granted 3,902 shares, increasing direct ownership by 45% to 12,644 units (SEC Form 4)

  4 - Blueprint Medicines Corp (0001597264) (Issuer)
• 523d
  CHIEF SCIENTIFIC OFFICER Carter Percy H. sold $340,033 worth of shares (2,659 units at $127.88), decreasing direct ownership by 5% to 54,206 units (SEC Form 4)

  4 - Blueprint Medicines Corp (0001597264) (Issuer)
• 530d
  Director Albers Jeffrey W. exercised 5,000 shares at a strike of $36.05 and sold $505,692 worth of shares (5,000 units at $101.14) (SEC Form 4)

  4 - Blueprint Medicines Corp (0001597264) (Issuer)
• 538d
  CHIEF OPERATING OFFICER Rossi Christina sold $228,557 worth of shares (2,274 units at $100.51), decreasing direct ownership by 3% to 64,718 units (SEC Form 4)

  4 - Blueprint Medicines Corp (0001597264) (Issuer)
• 552d
  CHIEF OPERATING OFFICER Rossi Christina sold $231,386 worth of shares (2,274 units at $101.75), decreasing direct ownership by 3% to 66,992 units (SEC Form 4)

  4 - Blueprint Medicines Corp (0001597264) (Issuer)
• 552d
  PRINCIPAL ACCOUNTING OFFICER Hurley Ariel exercised 2,752 shares at a strike of $54.13 and sold $283,819 worth of shares (2,752 units at $103.13) (SEC Form 4)

  4 - Blueprint Medicines Corp (0001597264) (Issuer)
• 586d
  CHIEF EXECUTIVE OFFICER Haviland Kate sold $216,461 worth of shares (2,498 units at $86.65), decreasing direct ownership by 1% to 165,929 units (SEC Form 4)

  4 - Blueprint Medicines Corp (0001597264) (Issuer)
• 594d
  CHIEF OPERATING OFFICER Rossi Christina sold $216,075 worth of shares (2,274 units at $95.02), decreasing direct ownership by 3% to 69,266 units (SEC Form 4)

  4 - Blueprint Medicines Corp (0001597264) (Issuer)
• 603d
  Director Albers Jeffrey W. sold $512,021 worth of shares (5,766 units at $88.80), decreasing direct ownership by 4% to 146,630 units (SEC Form 4)

  4 - Blueprint Medicines Corp (0001597264) (Issuer)
• 606d
  Director Albers Jeffrey W. exercised 7,500 shares at a strike of $36.05 and sold $658,500 worth of shares (7,500 units at $87.80) (SEC Form 4)

  4 - Blueprint Medicines Corp (0001597264) (Issuer)
• 613d
  CHIEF MEDICAL OFFICER Hewes L. Becker sold $890,639 worth of shares (10,095 units at $88.23), decreasing direct ownership by 25% to 30,419 units (SEC Form 4)

  4 - Blueprint Medicines Corp (0001597264) (Issuer)
• 613d
  CHIEF OPERATING OFFICER Rossi Christina sold $576,756 worth of shares (6,495 units at $88.80), decreasing direct ownership by 8% to 71,540 units (SEC Form 4)

  4 - Blueprint Medicines Corp (0001597264) (Issuer)
• 613d
  PRESIDENT, R & D Namouni Fouad sold $576,223 worth of shares (6,489 units at $88.80), decreasing direct ownership by 8% to 75,781 units (SEC Form 4)

  4 - Blueprint Medicines Corp (0001597264) (Issuer)
• 613d
  EVP AND CHIEF LEGAL OFFICER Mccain Tracey L sold $467,266 worth of shares (5,262 units at $88.80), decreasing direct ownership by 7% to 66,583 units (SEC Form 4)

  4 - Blueprint Medicines Corp (0001597264) (Issuer)
• 613d
  CHIEF COMMERCIAL OFFICER Lee Philina sold $331,490 worth of shares (3,733 units at $88.80), decreasing direct ownership by 8% to 41,996 units (SEC Form 4)

  4 - Blueprint Medicines Corp (0001597264) (Issuer)
• 613d
  CHIEF FINANCIAL OFFICER Landsittel Michael sold $469,219 worth of shares (5,284 units at $88.80), decreasing direct ownership by 7% to 72,924 units (SEC Form 4)

  4 - Blueprint Medicines Corp (0001597264) (Issuer)
• 613d
  PRINCIPAL ACCOUNTING OFFICER Hurley Ariel sold $117,749 worth of shares (1,326 units at $88.80), decreasing direct ownership by 7% to 16,944 units (SEC Form 4)

  4 - Blueprint Medicines Corp (0001597264) (Issuer)
• 613d
  CHIEF EXECUTIVE OFFICER Haviland Kate sold $1,434,209 worth of shares (16,151 units at $88.80), decreasing direct ownership by 9% to 168,427 units (SEC Form 4)

  4 - Blueprint Medicines Corp (0001597264) (Issuer)
• 613d
  CHIEF PEOPLE OFFICER Durso-Bumpus Debra sold $457,942 worth of shares (5,157 units at $88.80), decreasing direct ownership by 9% to 49,606 units (SEC Form 4)

  4 - Blueprint Medicines Corp (0001597264) (Issuer)
• 613d
  CHIEF SCIENTIFIC OFFICER Carter Percy H. sold $313,464 worth of shares (3,530 units at $88.80), decreasing direct ownership by 6% to 56,865 units (SEC Form 4)

  4 - Blueprint Medicines Corp (0001597264) (Issuer)
• 616d
  CHIEF MEDICAL OFFICER Hewes L. Becker was granted 11,000 shares, increasing direct ownership by 37% to 40,514 units (SEC Form 4)

  4 - Blueprint Medicines Corp (0001597264) (Issuer)
• 616d
  CHIEF COMMERCIAL OFFICER Lee Philina was granted 11,000 shares, increasing direct ownership by 32% to 45,729 units (SEC Form 4)

  4 - Blueprint Medicines Corp (0001597264) (Issuer)
• 616d
  PRINCIPAL ACCOUNTING OFFICER Hurley Ariel was granted 6,506 shares and sold $296,666 worth of shares (3,203 units at $92.62), increasing direct ownership by 22% to 18,270 units (SEC Form 4)

  4 - Blueprint Medicines Corp (0001597264) (Issuer)
• 616d
  EVP AND CHIEF LEGAL OFFICER Mccain Tracey L was granted 11,000 shares, increasing direct ownership by 18% to 71,845 units (SEC Form 4)

  4 - Blueprint Medicines Corp (0001597264) (Issuer)
• 616d
  CHIEF EXECUTIVE OFFICER Haviland Kate was granted 35,200 shares, increasing direct ownership by 24% to 184,578 units (SEC Form 4)

  4 - Blueprint Medicines Corp (0001597264) (Issuer)
• 616d
  CHIEF OPERATING OFFICER Rossi Christina was granted 13,200 shares, increasing direct ownership by 20% to 78,035 units (SEC Form 4)

  4 - Blueprint Medicines Corp (0001597264) (Issuer)
• 616d
  CHIEF SCIENTIFIC OFFICER Carter Percy H. was granted 11,000 shares, increasing direct ownership by 22% to 60,395 units (SEC Form 4)

  4 - Blueprint Medicines Corp (0001597264) (Issuer)
• 616d
  CHIEF FINANCIAL OFFICER Landsittel Michael was granted 11,000 shares, increasing direct ownership by 16% to 78,208 units (SEC Form 4)

  4 - Blueprint Medicines Corp (0001597264) (Issuer)
• 616d
  PRESIDENT, R & D Namouni Fouad was granted 13,200 shares, increasing direct ownership by 19% to 82,270 units (SEC Form 4)

  4 - Blueprint Medicines Corp (0001597264) (Issuer)
• 616d
  CHIEF PEOPLE OFFICER Durso-Bumpus Debra was granted 11,000 shares, increasing direct ownership by 25% to 54,763 units (SEC Form 4)

  4 - Blueprint Medicines Corp (0001597264) (Issuer)
• 624d
  CHIEF OPERATING OFFICER Rossi Christina sold $216,348 worth of shares (2,274 units at $95.14), decreasing direct ownership by 3% to 64,835 units (SEC Form 4)

  4 - Blueprint Medicines Corp (0001597264) (Issuer)
• 656d
  CHIEF EXECUTIVE OFFICER Haviland Kate sold $159,407 worth of shares (1,446 units at $110.24), decreasing direct ownership by 0.96% to 149,378 units (SEC Form 4)

  4 - Blueprint Medicines Corp (0001597264) (Issuer)
• 656d
  CHIEF OPERATING OFFICER Rossi Christina sold $250,455 worth of shares (2,274 units at $110.14), decreasing direct ownership by 3% to 67,109 units (SEC Form 4)

  4 - Blueprint Medicines Corp (0001597264) (Issuer)